Nadolol Found to be Noninferior to Propranolol for Infantile Hemangioma |
Journal Updates
eMediNexus Coverage from: 
Nadolol Found to be Noninferior to Propranolol for Infantile Hemangioma

0 Read Comments                

A study published in JAMA Pediatrics suggests that nadolol can be considered as a noninferior and probably an even better alternative to the standard propranolol for the treatment of infantile hemangioma (IH).The double-blind, randomized noninferiority study, conducted from 2016 to 2020 in Ontario, Canada, included 71 infants with a corrected gestational age of 1 to 6 months with hemangiomas more than 1.5 cm on the face or 3 cm or greater on any other part of the body, with the potential to resu...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now